 |
| President Moon Jae-in visited SK Bioscience in Seongnam, Gyeonggi Province as part of a field visit to a vaccine development company for a novel coronavirus infection (Corona 19), and is listening to explanations on cell culture from SK Bioscience Research Team Leader Lee Kun-se in the laboratory. 2020.10.15/News1 © News1 Reporter Yoo Seung-gwan |
Vaccinations, which were expected with the break of the Corona 19 pandemic, are raising concerns over side effects and supply disruptions. As the number of deaths after vaccination abroad continues, there are signs of vaccination rejection.
A significant number of vaccinations have been completed by the third quarter, and by the end of this year, the Korean quarantine authorities, which have been expecting the effect of collective immunity, are deepening.
According to Norwegian health officials, a total of 33 people died after vaccination on the 18th (local time) after the Pfizer-Bioentech vaccine. The number of Norwegians vaccinated with this vaccine is about 48,000, and considering that the vaccine is a direct cause or not, the side effects are not high, but the anxiety is considerable.
In California, USA, 6 residents who received the Corona 19 vaccine developed by Modena had a collective allergic reaction. The U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) decided that a high allergic reaction was found in a specific serial number vaccine among the vaccines produced by Modena, and they stopped taking the vaccine until detailed investigation.
The medical community and quarantine authorities emphasize that vaccination should be performed according to individual health conditions such as old age and underlying disease before vaccination. It is estimated that there are a number of factors that the basic physical strength to induce the formation of normal immunity, as well as side effects such as successive deaths and allergies abroad, were not supported.
Although cases of vaccination side effects are sporadic, there are increasing numbers of people who show rejection to the vaccine as they are reported steadily. According to the US political media The Hill, even in New York State, where the corona19 situation is severe, 12 to 29% of medical staff are refusing vaccination. They are reported to be concerned about potential side effects due to the short clinical period.
France, the’vaccination host country’, is also suffering from high public opinion against vaccination. According to the Wall Street Journal (WSJ), in an opinion poll conducted by Ipsos, a specialized public opinion poll, on 1,000 people from the 17th to the 20th of last month, 60% of the French were negative for vaccination.
In addition, supply is running against the explosive demand for vaccines, which is disrupting national vaccination targets. In the United States, an increasing number of states are seeking to obtain vaccines directly from pharmaceutical companies apart from the federal government. New York State is representative, and Governor Andrew Cuomo spoke to Pfizer for a direct purchase of the COVID-19 vaccine.
As the side effects and supply and demand problems of the Corona 19 vaccine emerge, voices of concern about disruptions in domestic supply and demand and vaccinations are starting to come out little by little. The government started vaccinations from February and completed vaccinations by September, and is expecting to form a group immunity around November. However, as supply disruptions and side effects issues arise, the overseas situation is closely watched.
In particular, in the case of side effects such as death and allergies in foreign countries where the vaccination was first started, there is a possibility that vaccine rejection cases may occur in Korea.
Jung Eun-kyung, head of the Central Defense Countermeasure Headquarters (Director of the Centers for Disease Control), said, “We believe that known adverse reactions such as fever or vomiting have indirectly affected the underlying disease.” I’ll take a look.”
He explained, “A case of aging death was reported last year when the influenza vaccination was inoculated, and investigations have been conducted in terms of worsening the underlying disease rather than a direct death from the species.” This means that it is unlikely to be a problem with the vaccine itself.
President Moon Jae-in also said at a New Year’s press conference on the 18th, “I still think that it is a difficult time to avoid vaccination because of anxiety about vaccines in Korea.” If it becomes a situation that requires a leading example, I will not avoid it.”